CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Pat McEnany on Q2 2019 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX)
Q2 2019 Earnings Conference Call
August 8, 2019 8:30 A.M. ET
Company Participants
Alicia Grande - Chief Financial Officer
Pat McEnany - Chairman and Chief Executive Officer
Dan Brennan - Chief Commercial Officer
Steve Miller - Chief Operating Officer and Chief Scientific Officer
Gary Ingenito - Chief Medical Officer and Head of Regulatory Affairs
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Joe Catanzaro - Piper Jaffray
Leland Gershell - Oppenheimer
Scott Henry - ROTH Capital
Presentation
Operator
Greetings and welcome to the Catalyst Pharmaceuticals Second Quarter 2019 Results Conference Call.